Omniscope appoints Dr. Iris Faull as Chief Medical Officer
Company News

Omniscope appoints Dr. Iris Faull as Chief Medical Officer

Dr. Iris Faull joins Omniscope as Chief Medical Officer.

Omniscope News

January 9, 2023

1 min

Barcelona, 9 January 2023 - Dr. Iris Faull joins deep biotech startup Omniscope as Chief Medical Officer, to support the company’s vision of bringing healthcare for everyone, everywhere.

“Iris joining us as CMO is a game-changer. Her vast experience in growing next-generation diagnostics further accelerates Omniscope’s clinical business pipeline and guides our strategic growth in the area of precision oncology.” - Dr. Holger Heyn, Omniscope Scientific Co-founder.

Dr. Iris Faull brings to Omniscope over 15 years of experience in Oncology and Precision Medicine. She previously led medical affairs and business development at prominent diagnostic companies including Guardant Health, NanoString Technologies, and Genomic Health. Dr. Faull works closely with leading clinicians, scientific societies, and patient associations, and is passionate about health economics, clinical data generation, and market access pathways in healthcare.

"The immune system is a key element in health and disease. I am thrilled to join Omniscope to improve early detection, monitoring, and cure of severe illnesses." - Dr. Iris Faull, MD, PhD.

About Omniscope:

Omniscope is a deep biotech startup whose technology decodes the immune system in High Resolution to inform therapy and develop diagnostics through the convergence of immune cell sequencing, digital biomarkers, and artificial intelligence. Omniscope envisions a world in which cutting-edge diagnostics are affordable and accessible to all. The company strives to empower advanced healthcare for everyone, everywhere.